MARKET

SUPN

SUPN

Supernus Pharma
NASDAQ
26.91
-0.36
-1.32%
After Hours: 26.00 -0.91 -3.38% 18:55 12/08 EST
OPEN
27.34
PREV CLOSE
27.27
HIGH
27.59
LOW
26.86
VOLUME
219.50K
TURNOVER
0
52 WEEK HIGH
42.09
52 WEEK LOW
21.99
MARKET CAP
1.47B
P/E (TTM)
62.39
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SUPN last week (1127-1201)?
Weekly Report · 5d ago
Supernus Pharmaceuticals (SUPN) Receives a Buy from Piper Sandler
TipRanks · 11/30 11:50
Weekly Report: what happened at SUPN last week (1120-1124)?
Weekly Report · 11/27 11:31
Supernus Pharma: Statement of changes in beneficial ownership of securities
Press release · 11/20 22:10
Weekly Report: what happened at SUPN last week (1113-1117)?
Weekly Report · 11/20 11:29
Supernus Pharma: Statement of changes in beneficial ownership of securities
Press release · 11/17 23:09
Supernus Pharma: Report of proposed sale of securities
Press release · 11/17 04:28
Supernus Pharma: Report of proposed sale of securities
Press release · 11/15 21:41
More
About SUPN
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company's diverse neuroscience portfolio includes treatments for epilepsy, migraine, attention deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. It is also developing a range of CNS product candidates, including potential treatments for hypomobility in PD, epilepsy, depression, and other CNS disorders. Its commercial portfolio of products includes Trokendi XR (topiramate) and Oxtellar XR (oxcarbazepine) for the treatment of epilepsy. Its APOKYN (apomorphine hydrochloride injection) is a product indicated for the acute, intermittent treatment of hypomobility in patients with advanced Parkinson's disease (PD).

Webull offers Supernus Pharmaceuticals Inc stock information, including NASDAQ: SUPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SUPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SUPN stock methods without spending real money on the virtual paper trading platform.